LianBio Quarterly Income Tax Expense (Benefit) in USD from Q3 2020 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
LianBio quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2020 to Q3 2023.
  • LianBio Income Tax Expense (Benefit) for the quarter ending September 30, 2023 was $586K, a 9667% increase year-over-year.
  • LianBio Income Tax Expense (Benefit) for the twelve months ending September 30, 2023 was $874K.
  • LianBio annual Income Tax Expense (Benefit) for 2022 was -$333K, a 164% decline from 2021.
  • LianBio annual Income Tax Expense (Benefit) for 2021 was $518K, a 12850% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $874K $586K +$580K +9667% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $294K $200K +$195K +3900% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $99K $438K +$432K +7200% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$333K -$350K +$685K +66.2% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-28
Q3 2022 -$1.02M $6K +$403K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$1.42M $5K -$970K -99.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$451K $6K -$969K -99.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $518K -$1.04M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 -$397K -$397K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $975K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $975K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q/A 2022-01-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.